Versus EmtricitabinePlus TDF - HIVandHepatitis.com
Versus EmtricitabinePlus TDF - HIVandHepatitis.com
Versus EmtricitabinePlus TDF - HIVandHepatitis.com
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Primary Efficacy Analysis: Comparison of the Two<br />
Treatment Strategies<br />
% of Patients with HBV DNA < 400 copies/mL (69 IU/mL)<br />
100<br />
90<br />
80<br />
82% FTC/<strong>TDF</strong><br />
82% <strong>TDF</strong><br />
Percentage (%)<br />
70<br />
60<br />
50<br />
40<br />
ITT: NC=F*<br />
30<br />
20<br />
10<br />
0<br />
0 4 8 12 24 36 48 60 72 84 96 108 120 132 144 156 168<br />
Weeks on Study<br />
Treatment<br />
<strong>TDF</strong><br />
FTC/<strong>TDF</strong><br />
Proportion of patients with HBV DNA < 169 copies/mL (29IU/mL): 80% <strong>TDF</strong> and 76% FTC/<strong>TDF</strong>
Change language